Functional Cure for Hepatitis B Virus: Challenges and Achievements.

Area of Science:

• Hepatology
• Virology
• Immunology

Background:

• Hepatitis B Virus (HBV) infection affects millions globally, causing significant health burdens.
• Chronic HBV infection is difficult to treat due to viral evasion of immune responses and lack of curative therapies.
• Current antiviral treatments suppress HBV but do not eliminate the virus or achieve a cure.

Purpose of the Study:

• To review the concept and immunological basis of a functional cure for Hepatitis B Virus (HBV).
• To explore emerging therapeutic strategies aimed at achieving a functional cure for HBV.
• To highlight the need for innovative approaches to manage chronic HBV infection.

Main Methods:

• Literature review of HBV epidemiology, clinical impact, and current treatment limitations.
• Discussion of the immunological mechanisms underlying a functional cure for HBV.
• Analysis of novel therapeutic modalities including RNA interference, entry inhibitors, nucleic acid polymers, and therapeutic vaccines.

Main Results:

• A functional cure for HBV involves suppressing viral replication and HBsAg, mitigating disease progression and transmission.
• Emerging therapies show promise in achieving a functional cure by targeting different stages of the HBV lifecycle and immune modulation.
• Significant challenges remain in developing curative strategies due to HBV's complex biology and immune evasion tactics.

Conclusions:

• A functional cure for HBV is an attainable goal that requires innovative therapeutic strategies.
• Further research into novel agents and combination therapies is essential to overcome the limitations of current treatments.
• Achieving a functional cure will significantly reduce the global burden of Hepatitis B Virus infection.